Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection
Clinical trial NCT00445146 · COMPLETED
Trial details
- NCT number
- NCT00445146
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2015-03-01
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.